These findings reveal that the downregulation of the IL-6-driven JAK1/STAT3 axis by a combination of digilanid C and ES is a key mechanism for alleviating the pathogenesis of cardiomyocyte dyslipidemia, linking aberrant lipid metabolism in CHF to CGCs overactivation. The gene discussed is JAK1; the disease is congestive heart failure.